Cases 21 - 30 of 106
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al.
as 1:2021cv01485
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Aurobindo Pharma USA Inc. et al
as 1:2021cv01407
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2021cv01330
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alkem Laboratories Ltd., Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv01062
Plaintiff:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Newron Pharmaceuticals S.p.A et al v. MSN Laboratories Private Limited et al
as 1:2021cv00843
Defendant:
Aurobindo Pharma USA Inc., Prinston Pharmaceutical, Inc., MSN Laboratories Private Limited and others
Plaintiff:
Newron Pharmaceuticals S.p.A., MDD US Operations, LLC and Zambon S.p.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2021cv00662
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00425
Defendant:
Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC and others
Plaintiff:
Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Hikma Pharmaceuticals USA Inc. et al v. Aurobindo Pharma Limited et al
as 1:2021cv00228
Plaintiff:
Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals LLC
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00022
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff:
PBG Puerto Rico LLC, Pfizer Inc., PF PRISM C.V. and others
Cause Of Action: 35 U.S.C. § 271
Merz Pharmaceuticals, LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2020cv01760
Plaintiff:
Merz Pharmaceuticals, LLC and Merz North America, Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
